(Total Views: 631)
Posted On: 02/05/2021 6:55:04 PM
Post# of 148899
Doctor in the house? Your opinion?
If/when I take vaccine -
It will NOT be any of the mRNA types out now: "Once inside your cells, the mRNA instructs your cells’ protein factories to make copies of these viral proteins. These then stimulate your immune system to mount a protective immune response. Too new, law of unintendeds
Novavax is not mRNA, but much closer to traditional.
"The Novavax vaccine, NVX-CoV2373, contains purified pieces of the spike protein of SARS-CoV-2, the virus that causes COVID-19. These proteins are administered with an adjuvant, a molecule that enhances the immune response.
"Early clinical trials were performed in Australia. In the phase 1 clinical trials, the vaccine was generally well-tolerated and produced strong antibody responses, stronger than what we see in patients recovering from COVID-19.
Results should be out soon: "In September, Novavax launched a phase 3 clinical trial in the United Kingdom. Further large-scale clinical trials are planned for other countries in late 2020 and early 2021.
https://theconversation.com/what-do-we-know-a...for-149522
*********************
"Jan. 29 after the company said its coronavirus vaccine was 89.3% effective in a Phase 3 test.
"Also bullish, the experimental drug was 95.6% effective at blocking the original strain and 85.6% effective against the mutated U.K. strain. It was also 60% effective in preventing Covid-19 resulting from the South Africa variant.
"Novavax's drug also outperformed experimental vaccines from Johnson & Johnson (JNJ) and AstraZeneca (AZN)
"Novavax's technology uses moth cells to develop molecules for vaccine development at a faster rate than the typical process, which relies on chicken eggs.
TIA.
"Hey, Fauci! How was your trip to Wuhan?"
If/when I take vaccine -
It will NOT be any of the mRNA types out now: "Once inside your cells, the mRNA instructs your cells’ protein factories to make copies of these viral proteins. These then stimulate your immune system to mount a protective immune response. Too new, law of unintendeds
Novavax is not mRNA, but much closer to traditional.
"The Novavax vaccine, NVX-CoV2373, contains purified pieces of the spike protein of SARS-CoV-2, the virus that causes COVID-19. These proteins are administered with an adjuvant, a molecule that enhances the immune response.
"Early clinical trials were performed in Australia. In the phase 1 clinical trials, the vaccine was generally well-tolerated and produced strong antibody responses, stronger than what we see in patients recovering from COVID-19.
Results should be out soon: "In September, Novavax launched a phase 3 clinical trial in the United Kingdom. Further large-scale clinical trials are planned for other countries in late 2020 and early 2021.
https://theconversation.com/what-do-we-know-a...for-149522
*********************
"Jan. 29 after the company said its coronavirus vaccine was 89.3% effective in a Phase 3 test.
"Also bullish, the experimental drug was 95.6% effective at blocking the original strain and 85.6% effective against the mutated U.K. strain. It was also 60% effective in preventing Covid-19 resulting from the South Africa variant.
"Novavax's drug also outperformed experimental vaccines from Johnson & Johnson (JNJ) and AstraZeneca (AZN)
"Novavax's technology uses moth cells to develop molecules for vaccine development at a faster rate than the typical process, which relies on chicken eggs.
TIA.
"Hey, Fauci! How was your trip to Wuhan?"
(1)
(0)Scroll down for more posts ▼
